Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-{2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine

A process for preparing an anhydrous benzoate salt in crystalline form having the formula I: and the corresponding benzoate monohydrate in crystalline form. The benzoate salts and pharmaceutical compositions thereof are selective kappa-receptor agonists, and are useful as analgesics, anesthetics, an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CASTALDI MICHAEL J, QUALLICH GEORGE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CASTALDI MICHAEL J
QUALLICH GEORGE
description A process for preparing an anhydrous benzoate salt in crystalline form having the formula I: and the corresponding benzoate monohydrate in crystalline form. The benzoate salts and pharmaceutical compositions thereof are selective kappa-receptor agonists, and are useful as analgesics, anesthetics, anti-inflammatory or neuroprotective agents, or in the treatment of arthritis, stroke or functional bowel disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2004235936A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2004235936A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2004235936A13</originalsourceid><addsrcrecordid>eNqNjk0KwjAUhLtxIeodAi5U8IEmVXAporjqproSKdG-0kKaF5IIRvEo3tX6cwBXM98wA9OOnisbnJdKVRqZ1GXILV1c43JWk6Y3S4_shPpGb-Ok8o5RwYZ8kI5FOgIBn9E1QAJ3DocEavRlUA3GMEzAWDJBybrSBGdpT6SDGpkSGzl-Uw5ffMBnaIK1pKq8edSNWoVUDns_7UT9zXq32gIaytAZeUaNPtunfDKJuZgtxHw5Ff-1XnTmU-Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-{2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine</title><source>esp@cenet</source><creator>CASTALDI MICHAEL J ; QUALLICH GEORGE</creator><creatorcontrib>CASTALDI MICHAEL J ; QUALLICH GEORGE</creatorcontrib><description>A process for preparing an anhydrous benzoate salt in crystalline form having the formula I: and the corresponding benzoate monohydrate in crystalline form. The benzoate salts and pharmaceutical compositions thereof are selective kappa-receptor agonists, and are useful as analgesics, anesthetics, anti-inflammatory or neuroprotective agents, or in the treatment of arthritis, stroke or functional bowel disease.</description><edition>7</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20041125&amp;DB=EPODOC&amp;CC=US&amp;NR=2004235936A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20041125&amp;DB=EPODOC&amp;CC=US&amp;NR=2004235936A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CASTALDI MICHAEL J</creatorcontrib><creatorcontrib>QUALLICH GEORGE</creatorcontrib><title>Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-{2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine</title><description>A process for preparing an anhydrous benzoate salt in crystalline form having the formula I: and the corresponding benzoate monohydrate in crystalline form. The benzoate salts and pharmaceutical compositions thereof are selective kappa-receptor agonists, and are useful as analgesics, anesthetics, anti-inflammatory or neuroprotective agents, or in the treatment of arthritis, stroke or functional bowel disease.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjk0KwjAUhLtxIeodAi5U8IEmVXAporjqproSKdG-0kKaF5IIRvEo3tX6cwBXM98wA9OOnisbnJdKVRqZ1GXILV1c43JWk6Y3S4_shPpGb-Ok8o5RwYZ8kI5FOgIBn9E1QAJ3DocEavRlUA3GMEzAWDJBybrSBGdpT6SDGpkSGzl-Uw5ffMBnaIK1pKq8edSNWoVUDns_7UT9zXq32gIaytAZeUaNPtunfDKJuZgtxHw5Ff-1XnTmU-Y</recordid><startdate>20041125</startdate><enddate>20041125</enddate><creator>CASTALDI MICHAEL J</creator><creator>QUALLICH GEORGE</creator><scope>EVB</scope></search><sort><creationdate>20041125</creationdate><title>Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-{2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine</title><author>CASTALDI MICHAEL J ; QUALLICH GEORGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2004235936A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CASTALDI MICHAEL J</creatorcontrib><creatorcontrib>QUALLICH GEORGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CASTALDI MICHAEL J</au><au>QUALLICH GEORGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-{2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine</title><date>2004-11-25</date><risdate>2004</risdate><abstract>A process for preparing an anhydrous benzoate salt in crystalline form having the formula I: and the corresponding benzoate monohydrate in crystalline form. The benzoate salts and pharmaceutical compositions thereof are selective kappa-receptor agonists, and are useful as analgesics, anesthetics, anti-inflammatory or neuroprotective agents, or in the treatment of arthritis, stroke or functional bowel disease.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2004235936A1
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-{2-[N-methyl-N-4-(N-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T16%3A47%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CASTALDI%20MICHAEL%20J&rft.date=2004-11-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2004235936A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true